- ¥2bn
- ¥1bn
- ¥1bn
- 15
- 24
- 55
- 19
Annual income statement for SecuAvail, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
Standards: | JAS | JAS | JAS | JAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,200 | 957 | 1,029 | 1,099 | 1,149 |
Cost of Revenue | |||||
Gross Profit | 497 | 373 | 414 | 443 | 451 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,153 | 1,051 | 1,068 | 1,171 | 1,115 |
Operating Profit | 46.9 | -94.3 | -39.2 | -71.9 | 34.2 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 61.8 | -85.6 | -35.2 | 344 | 36.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 46.2 | -112 | -44 | 229 | 42.8 |
Net Income Before Extraordinary Items | |||||
Net Income | 46.2 | -112 | -44 | 229 | 42.8 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 46.2 | -112 | -44 | 229 | 42.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.1 | -14.4 | -5.35 | 33.2 | 5.64 |
Dividends per Share | |||||
Special Dividends per Share |